following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv).
.
.
"there is an issue that needs to be addressed in terms of the narrative the health trust tried to present and mislead the inquest and cover up what actually happened.
.
.
meet other global citizens who care about the same issues you do. keep updated on what they're doing to change the world.
.
stephen silberstein, md, director, jefferson university headache center.
.